- Home
- CHRO vs SOBR Comparison
CHRO vs SOBR Comparison
Compare CHRO & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- SOBR
- Stock Information
- Founded
- CHRO 2002
- SOBR 2004
- Country
- CHRO United States
- SOBR United States
- Employees
- CHRO N/A
- SOBR N/A
- Industry
- CHRO
- SOBR Newspapers/Magazines
- Sector
- CHRO
- SOBR Consumer Discretionary
- Exchange
- CHRO Nasdaq
- SOBR Nasdaq
- Market Cap
- CHRO 4.2M
- SOBR 3.7M
- IPO Year
- CHRO 2024
- SOBR N/A
- Fundamental
- Price
- CHRO $0.60
- SOBR $1.02
- Analyst Decision
- CHRO Strong Buy
- SOBR
- Analyst Count
- CHRO 1
- SOBR 0
- Target Price
- CHRO N/A
- SOBR N/A
- AVG Volume (30 Days)
- CHRO 121.3K
- SOBR 396.9K
- Earning Date
- CHRO 11-13-2024
- SOBR 11-14-2024
- Dividend Yield
- CHRO N/A
- SOBR N/A
- EPS Growth
- CHRO N/A
- SOBR N/A
- EPS
- CHRO N/A
- SOBR N/A
- Revenue
- CHRO N/A
- SOBR $183,859.00
- Revenue This Year
- CHRO N/A
- SOBR $2,351.49
- Revenue Next Year
- CHRO N/A
- SOBR N/A
- P/E Ratio
- CHRO N/A
- SOBR N/A
- Revenue Growth
- CHRO N/A
- SOBR 27.39
- 52 Week Low
- CHRO $0.45
- SOBR $0.86
- 52 Week High
- CHRO $6.00
- SOBR $88.00
- Technical
- Relative Strength Index (RSI)
- CHRO 48.49
- SOBR 19.95
- Support Level
- CHRO $0.55
- SOBR $0.86
- Resistance Level
- CHRO $0.71
- SOBR $5.70
- Average True Range (ATR)
- CHRO 0.10
- SOBR 0.40
- MACD
- CHRO -0.00
- SOBR -0.38
- Stochastic Oscillator
- CHRO 23.98
- SOBR 1.01
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending SOBRsafe software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.